Type: Pancreatic cancer

Associate Professor Marina Pajic and her team have identified a molecular pathway that controls communication between pancreatic cancer cells and stromal cells.

A/Prof Griffin will conduct pre-clinical tests of a much needed new combination treatment for patients with advanced pancreatic and bowel cancers.

Researchers will use cutting-edge imaging technology and lab models that mimic pancreatic cancer and watch tumour response to treatment.

Researchers will test a dual treatment approach that targets collagen production in pancreatic cancer tumours.

This project aims to improve treatment by monitoring an individual’s response to immunotherapy. 

This innovative research could be a breakthrough in treating pancreatic cancer and improving survival outcomes.

Associate Professor Phoebe Phillips and her team have come up with a new way to target the cells that help the spread of aggressive pancreatic cancer.

This project aims to develop a way to increase the effectiveness of chemotherapy in pancreatic cancer using a dual treatment approach that targets the production of protective tissue in the tumour.

This project aims to develop a tailored treatment approach for pancreatic cancer, providing more effective options and boosting the chances of a good outcome.

Professor John Rasko

If this treatment is shown to be effective, it will provide much-needed hope for patients who receive the devastating diagnosis of pancreatic cancer.